[ Clinical study on <font color="blue">treatment_1</font> of endometriosis - related infertility patients by <font color="blue">laparoscopic_3</font> <font color="blue">surgery_3</font> <font color="blue">in_2</font> <font color="blue">combination_2</font> <font color="blue">of_2</font> <font color="blue">quyu_2</font> <font color="blue">jiedu_2</font> <font color="blue">recipe_2</font> <font color="blue">]_2</font> . 
<br>
<br> OBJECTIVE To study the clinical efficacy of the <font color="blue">laparoscopic_5</font> <font color="blue">surgery_5</font> <font color="blue">in_4</font> <font color="blue">combination_4</font> <font color="blue">of_4</font> <font color="blue">Quyu_4</font> <font color="blue">Jiedu_4</font> <font color="blue">Recipe_4</font> <font color="blue">(_3</font> <font color="blue">QYJDR_3</font> <font color="blue">)_3</font> on endometriosis ( EMs)-related infertility patients . 
<br> METHODS 130 EMs - related infertility patients of blood stasis and toxin accumulation syndrome diagnosed and treated by <font color="blue">laparoscopic_4</font> <font color="blue">surgery_4</font> were randomly assigned to two groups , i.e. , the <font color="blue">test_2</font> <font color="blue">group_2</font> ( 75 cases ) and the <font color="blue">control_2</font> <font color="blue">group_2</font> ( 55 cases ) . All patients received <font color="blue">routine_2</font> <font color="blue">progesterone_4</font> <font color="blue">treatment_4</font> <font color="blue">after_3</font> <font color="blue">laparoscopic_5</font> <font color="blue">surgery_5</font> <font color="blue">._5</font> <font color="blue">QYJDR_4</font> was given to patients in the <font color="blue">test_1</font> <font color="blue">group_1</font> after <font color="blue">laparoscopic_3</font> <font color="blue">surgery_3</font> <font color="blue">,_3</font> lasting for twelve months . The pregnancy rate within one year after <font color="blue">laparoscopic_2</font> <font color="blue">surgery_2</font> were compared between the two groups . The <font color="blue">Chinese_1</font> <font color="blue">medicine_1</font> <font color="blue">syndrome_1</font> <font color="blue">integrals_1</font> <font color="blue">,_1</font> <font color="blue">serum_1</font> <font color="blue">endometrium_1</font> <font color="blue">antibody_1</font> <font color="blue">(_1</font> <font color="blue">EMAb_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">cancer_1</font> <font color="blue">antigen_1</font> <font color="blue">125_1</font> <font color="blue">(_1</font> <font color="blue">CA125_1</font> <font color="blue">)_1</font> levels were compared between <font color="blue">before_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> and three months <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> <font color="blue">._2</font> 
<br> RESULTS The pregnancy rate within one year after <font color="blue">laparoscopic_3</font> <font color="blue">surgery_3</font> was higher in the <font color="blue">test_2</font> <font color="blue">group_2</font> <font color="blue">than_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">control_2</font> <font color="blue">group_2</font> [ 61.33% ( 46/75 ) vs 45.45% ( 25/55 ) ] , showing significant difference ( P<0.05 ) . The <font color="blue">Chinese_1</font> <font color="blue">medicine_1</font> <font color="blue">syndrome_1</font> <font color="blue">integral_1</font> was ( 16.07 + /- 6.77 ) score and ( 7.25 + /- 3.27 ) score before and 3 months after <font color="blue">drug_2</font> <font color="blue">therapy_2</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">test_2</font> <font color="blue">group_2</font> <font color="blue">,_2</font> while it was ( 15.92 + /- 7.51 ) score and ( 12.73 + /- 6.12 ) score in the <font color="blue">control_2</font> <font color="blue">group_2</font> <font color="blue">._2</font> The <font color="blue">Chinese_1</font> <font color="blue">medicine_1</font> <font color="blue">syndrome_1</font> <font color="blue">integral_1</font> <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> was lower than that <font color="blue">before_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> in the same group . Besides , the integral difference between <font color="blue">before_1</font> <font color="blue">and_1</font> <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> was higher in the <font color="blue">test_2</font> <font color="blue">group_2</font> <font color="blue">than_1</font> <font color="blue">in_1</font> <font color="blue">the_1</font> <font color="blue">control_2</font> <font color="blue">group_2</font> [ ( 9.12 + /- 6.16 ) score vs ( 3.48 + /- 2.06 ) score ) ] , showing statistical difference ( P<0.05 ) . After three - month <font color="blue">drug_1</font> <font color="blue">therapy_1</font> <font color="blue">,_1</font> the serum EMAb negative conversion rate was obviously higher in the <font color="blue">test_2</font> <font color="blue">group_2</font> than in the <font color="blue">control_2</font> <font color="blue">group_2</font> ( 44.44% vs 15.62% ) , showing statistical difference ( P<0.05 ) . The serum CA125 level was ( 31.88 + /- 15.78 ) U / mL <font color="blue">before_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> and ( 18.82 + /- 10.08 ) U / mL three months <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> in the <font color="blue">test_1</font> <font color="blue">group_1</font> <font color="blue">,_1</font> while it was ( 30.63 + /- 19.28 ) U / mL and ( 18.05 + /- 11.20 ) U / mL respectively in the <font color="blue">control_2</font> <font color="blue">group_2</font> <font color="blue">._2</font> It was lowered <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> in the two groups with statistical difference ( P<0.05 ) . There was no statistical difference between the two groups <font color="blue">after_1</font> <font color="blue">drug_2</font> <font color="blue">therapy_2</font> ( P>0.05 ) . 
<br> CONCLUSIONS The <font color="blue">laparoscopic_3</font> <font color="blue">surgery_3</font> <font color="blue">in_2</font> <font color="blue">combination_2</font> <font color="blue">of_2</font> <font color="blue">QYJDR_2</font> could effectively improve clinical symptoms of EMs patients of blood stasis and toxin accumulation syndrome , promote negative conversion of EMAb , lower serum CA125 levels , and elevate the clinical pregnancy rate . <font color="blue">QYJDR_2</font> is an effective formula in treatment of EMs - related infertility .